GE Aerospace’s 2024 journey showcases resilience and strategic transformation, achieving significant growth despite industry challenges. Explore key insights now.
GE Aerospace’s Q3 2024 performance showcases resilience with a 28% surge in orders, a 6% revenue increase, and strategic investments paving the way for future growth.
Boston Scientific’s Q3 2023 earnings report highlights significant growth in cardiology, with year-to-date U.S. growth at 27%, driven by successful product launches and innovation.
